HealthStream, Inc. Q2 2026 Earnings Recap

HSTM Q2 2026 August 5, 2026

Get alerts when HSTM reports next quarter

Shares rose 6.3% following Q2 results as revenue growth of 12.5% and adjusted EBITDA growth of 16.9% both came in ahead of expectations, supported by strong traction in the career networks segment and increased full-year guidance.

Earnings Per Share Beat

$0.23 vs $0.17 est.

+38.6% surprise

Revenue Beat

83732000 vs 80822740 est.

+3.6% surprise

Market Reaction

1-Day +0.39%

5-Day +1.25%

See HSTM alongside your other holdings

Add to your portfolio — free

Key Takeaways

Revenue reached a record $83.7 million, up 12.5% year-over-year.
Adjusted EBITDA increased 16.9% to $20.6 million, with operating income up 41.4% year-over-year.
Management raised full-year revenue and adjusted EBITDA guidance based on strong first-half results.
Career networks, particularly myClinicalExchange, expanded 29% YoY, driven by investments including 15 new positions added beyond initial budgets.
Company highlighted a strong balance sheet with $66.7 million cash, no long-term debt, and available line of credit, supporting M&A and strategic investments.

This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit HSTM on AllInvestView.

Previous Q1 2026